MCLEAN, Va.--(BUSINESS WIRE)--Zephyr AI, a high-growth healthcare technology company committed to developing AI-Enabled Composite Biomarkers to expand the horizon of precision medicine in cancer drug ...

The Zephyr-7B model has been trained using a three-step strategy. The first step involves distilled supervised fine-tuning using the Ultra Chat dataset. This dataset, comprising 1.47 million ...